SCHEMBL9733951

SCHEMBL9733951

CN(C)C(=S)Oc1ccc(C(=O)CCC(=O)O)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.51
ALDH1A1 P00352 4/20 0.49
CYP1A2 P05177 2/20 0.49
CYP2C19 P33261 2/20 0.49
HPGD P15428 1/20 0.49
HSD17B10 Q99714 1/20 0.49
PDE4B Q07343 1/20 0.49
USP5 P45974 1/20 0.47
NR4A2 P43354 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
RAB9A P51151 3/20 0.46
LMNA P02545 2/20 0.46
FFAR1 O14842 1/20 0.46
HIF1A Q16665 1/20 0.46
GAA P10253 1/20 0.44
MAPT P10636 3/20 0.43
NPC1 O15118 2/20 0.43
HTT P42858 2/20 0.42
EGFR P00533 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10691629 0.85 MAPT (0.54) KMT2AALDH1A1HSD17B10PDE4BSMN1; SMN2
SCHEMBL10793843 0.80 RAB9A (0.43) KMT2AALDH1A1SMN1; SMN2RAB9ALMNA
SCHEMBL2310682 0.79 KMT2A (0.59) KMT2AALDH1A1CYP1A2CYP2C19HPGD
SCHEMBL9711102 0.77 MAPT (0.53) KMT2AALDH1A1CYP1A2CYP2C19HPGD
SCHEMBL6540729 0.76 KDM4E (0.45) ALDH1A1HPGDHSD17B10RAB9ALMNA
SCHEMBL503582 0.75 PDE4B (0.80) KMT2AALDH1A1CYP1A2CYP2C19HPGD
SCHEMBL10885925 0.75 NR4A2 (0.63) KMT2AALDH1A1CYP1A2CYP2C19HPGD
SCHEMBL11305905 0.74 CA1 (0.56) KMT2AALDH1A1L3MBTL1SMN1; SMN2RAB9A
SCHEMBL10353454 0.74 NR4A2 (0.81) KMT2AALDH1A1CYP1A2CYP2C19HPGD
SCHEMBL6553235 0.73 LMNA (0.55) KMT2AALDH1A1HSD17B10SMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5135940-A Antiallegens, antiinflammatory agents MERCK FROSST CANADA, INC. (CA) 1992-08-04 US disclosed
US-4876246-A Benzo[a]phenothiazines and hydro-derivatives for inhibiting leukotriene biosynthesis MERCK FROSST CANADA, INC. (CA) 1989-10-24 US disclosed
EP-0252639-A1 Leukotriene antagonists MERCK FROSST CANADA INC. (CA) 1988-01-13 EP disclosed
EP-0104885-B1 LEUKOTRIENE ANTAGONISTS, THEIR PRODUCTION, AND COMPOSITIONS CONTAINING THEM MERCK FROSST CANADA INC. (CA) 1986-06-04 EP disclosed
EP-0156233-A2 Use of leukotriene antagonists for producing cytoprotective pharmaceutical compositions and process for producing cytoprotective pharmaceutical compositions MERCK & CO. INC. (US) 1985-10-02 EP disclosed
EP-0104885-A1 Leukotriene antagonists, their production, and compositions containing them MERCK FROSST CANADA INC. (CA) 1984-04-04 EP disclosed